Allworth Financial’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-111
| Closed | -$4.76K | – | 3879 |
|
|
2024
Q2 | $4.76K | Buy |
111
+47
| +73% | +$2.02K | ﹤0.01% | 2549 |
|
|
2024
Q1 | $2.71K | Hold |
64
| – | – | ﹤0.01% | 2695 |
|
|
2023
Q4 | $2.71K | Buy |
64
+19
| +42% | +$806 | ﹤0.01% | 2537 |
|
|
2023
Q3 | $983 | Buy |
+45
| New | +$983 | ﹤0.01% | 2856 |
|
|
2023
Q2 | – | Sell |
-6
| Closed | -$147 | – | 3413 |
|
|
2023
Q1 | $147 | Hold |
6
| – | – | ﹤0.01% | 3063 |
|
|
2022
Q4 | $189 | Buy |
+6
| New | +$189 | ﹤0.01% | 2791 |
|